Skip to main content
Clinical Trials/CTRI/2017/12/010795
CTRI/2017/12/010795
Not yet recruiting
未知

â??Comparative 6 month clinical study of Modified Coronally Advanced Flap(MCAF) and Minimally Invasive Coronally Advanced Flap(MICAF) for the treatment of multiple adjacent gingival recession defectsâ??

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with bilateral maxillary gingival recessions â?¥2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype â?¥1mm without any systemic complications
Sponsor
Manipal college of Dental Sciences Mangalore
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who agree to participate in the study by signing the informed consent.
  • 2\. Presence of bilateral maxillary gingival recessions \>\=2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype \>\=1mm.
  • 3\. Difference in depth of the gingival recessions between the right \& left side \<\=1mm \& difference in clinical attachment \<\=2mm.
  • 4\. Probing depth less than 3mm \& full mouth plaque score \<20%, full mouth gingival index score \<20%.
  • 5\. Properly aligned teeth in the arch without any malposition

Exclusion Criteria

  • 1\. Patients with systemically compromised health \& contraindicated for periodontal surgery.
  • 2\. Periodontal surgical treatment during the previous 24 months on the involved sites.
  • 3\. Current pregnancy or lactation.
  • 4\. Patient with smoking habit.
  • 5\. Patient with unjustified absence for scheduled visits, continued traumatic tooth brushing,faulty plaque control measures.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.
EUCTR2007-001975-12-BEPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairment
EUCTR2007-001975-12-FIPIERRE FABRE MEDICAMENT - IDPF210
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairment
EUCTR2007-001975-12-FRPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson’s disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Fatigue symptoms in Parkinson's disease.MedDRA version: 9.1 Level: LLT Classification code 10013113 Term: Disease Parkinson's
EUCTR2007-002195-34-FRPIERRE FABRE MEDICAMENT120
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.
EUCTR2007-001975-12-ATPIERRE FABRE MEDICAMENT - IDPF210